Literature DB >> 29307005

Effect of cerebral embolus size on the timing of cardiac surgery for infective endocarditis in patients with neurological complications.

Yong Kyun Kim1, Choong Gon Choi2, Jiwon Jung3,4, Shi Nae Yu3,5, Ju Young Lee3,6, Yong Pil Chong3, Sung-Han Kim3, Sang-Oh Lee3, Sang-Ho Choi3, Jun Hee Woo3, Yang Soo Kim7.   

Abstract

The optimal timing of cardiac surgery remains unclear for patients with neurological complications of infective endocarditis (IE). However, neuroimaging findings may allow more refined clinical decision-making. We analyzed clinical and advanced neuroimaging data for 135 patients with IE who had preoperatively diagnosed ischemic cerebral complications (86 patients) or hemorrhagic complications (49 patients), between January 1997 and May 2013. The effect of early surgery (within 3 and 7 days of ischemic and hemorrhagic complications respectively) on in-hospital mortality and 1-year adverse outcomes (mortality, relapse, or new embolic events) was estimated. Small cerebral emboli (≤2 cm) led to early surgery (cases with ischemic complications: 57% vs 26%, p = 0.04; cases with hemorrhagic complications: 56% vs 13%, p = 0.02). Early surgery was not significantly associated with increased rates of in-hospital mortality and 1-year adverse outcomes among patients with ischemic complications (14% vs 9%, odds ratio [OR] 1.67, 95% confidence interval [CI] 0.44-6.38, p = 0.52; 17% vs 14%, OR 1.27, 95% CI 0.39-4.14, p = 0.7 respectively). Only 1 patient (4%) with hemorrhagic complications experienced in-hospital mortality in the early surgery group, and early surgery was not significantly associated with 1-year adverse outcomes (21% vs 12%, OR 1.93, 95% CI 0.41-9.16, p = 0.46). The risks of in-hospital mortality and 1-year adverse outcome were not increased, even if cardiac surgery had been carried out earlier than previously described. Our findings suggest that early surgery, when indicated, may be performed for patients with IE and neurological complications, especially if the cerebral embolus has a diameter of ≤2 cm.

Entities:  

Mesh:

Year:  2018        PMID: 29307005     DOI: 10.1007/s10096-017-3148-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  35 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

2.  Hospital-acquired infective endocarditis: should the definition be broadened?

Authors:  Ronen Ben-Ami; Michael Giladi; Yehuda Carmeli; Ruth Orni-Wasserlauf; Yardena Siegman-Igra
Journal:  Clin Infect Dis       Date:  2004-03-01       Impact factor: 9.079

Review 3.  Critical Questions About Left-Sided Infective Endocarditis.

Authors:  J Alberto San Román; Isidre Vilacosta; Javier López; Cristina Sarriá
Journal:  J Am Coll Cardiol       Date:  2015-09-01       Impact factor: 24.094

Review 4.  Arterial territories of human brain: brainstem and cerebellum.

Authors:  L Tatu; T Moulin; J Bogousslavsky; H Duvernoy
Journal:  Neurology       Date:  1996-11       Impact factor: 9.910

Review 5.  Clinical practice. Infective endocarditis.

Authors:  Bruno Hoen; Xavier Duval
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245

Review 6.  Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Imad M Tleyjeh; Michael J Rybak; Bruno Barsic; Peter B Lockhart; Michael H Gewitz; Matthew E Levison; Ann F Bolger; James M Steckelberg; Robert S Baltimore; Anne M Fink; Patrick O'Gara; Kathryn A Taubert
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

7.  Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke.

Authors:  Bruno Barsic; Stuart Dickerman; Vladimir Krajinovic; Paul Pappas; Javier Altclas; Giampiero Carosi; José H Casabé; Vivian H Chu; Francois Delahaye; Jameela Edathodu; Claudio Querido Fortes; Lars Olaison; Ana Pangercic; Mukesh Patel; Igor Rudez; Syahidah Syed Tamin; Josip Vincelj; Arnold S Bayer; Andrew Wang
Journal:  Clin Infect Dis       Date:  2012-10-16       Impact factor: 9.079

Review 8.  Impact of stroke on therapeutic decision making in infective endocarditis.

Authors:  Laurent Derex; Eric Bonnefoy; François Delahaye
Journal:  J Neurol       Date:  2009-10-30       Impact factor: 4.849

9.  Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study.

Authors:  Franck Thuny; Jean-François Avierinos; Christophe Tribouilloy; Roch Giorgi; Jean-Paul Casalta; Loïc Milandre; Amel Brahim; Georges Nadji; Alberto Riberi; Frédéric Collart; Sebastien Renard; Didier Raoult; Gilbert Habib
Journal:  Eur Heart J       Date:  2007-03-15       Impact factor: 29.983

10.  The impact of preoperative neurological events in patients suffering from native infective valve endocarditis.

Authors:  Manuel Wilbring; Linda Irmscher; Konstantin Alexiou; Klaus Matschke; Sems-Malte Tugtekin
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-03-04
View more
  2 in total

1.  Inactive large cerebral hemorrhage is not exacerbated by the adjustment of anticoagulation post open-heart surgery.

Authors:  Ayaka Satoh; Shin Yajima; Naosumi Sekiya; Sachiko Yamazaki; Hisashi Uemura; Daisuke Ueda; Hiroe Tanaka; Mitsuhiro Yamamura; Taichi Sakaguchi
Journal:  J Cardiol Cases       Date:  2021-05-13

2.  Impact of Operative Timing in Infective Endocarditis with Cerebral Embolism-The Risk of Intermediate Deterioration.

Authors:  Alexey Dashkevich; Georg Bratkov; Yupeng Li; Dominik Joskowiak; Sven Peterss; Gerd Juchem; Christian Hagl; Maximilian Luehr
Journal:  J Clin Med       Date:  2021-05-15       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.